Univariate (t test, Chi square test) and multivariate Cox regression analyses were performed to examine the effect of imaging intensity on the rates of asymptomatic surveillance-detected recurrence (ASDR) and subsequent treatment outcomes in patients with access to immune checkpoint inhibitors (ICIs) and targeted therapy (TT).
Scientific Publications
Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic Profiling
In the present study, the researchers sought to systematically analyze the gene expression pattern in the melanoma-immune microenvironment and its association with prognosis.
Melanoma incidence among non-Hispanic whites in all 50 US states from 2001 through 2015
In order to analyze changes in melanoma incidence, the authors gathered data from all 50 states and conducted age-period-cohort analyses to describe the combined impact of age, era, and cohort on incidence rates.
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy vs placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): A randomised, double-blind, placebo-controlled, phase 2 trial
Researchers conducted this randomised, double-blind, placebo-controlled, phase 2 trial to test the safety and effectiveness of adjuvant nivolumab plus ipilimumab or nivolumab monotherapy vs a placebo in patients with stage IV melanoma with no evidence of disease.